Viscoelastic Supramolecular Networks Based on Guanidinium‐Oxyanion Interactions
Journal of Polymer Science · 2025-06 · 63 (11) · 2363-2370
DOI: 10.1002/pol.20250048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Polymer Science, online erschienen am 25.04.2025. Verfasst von Oliver G. Venablerose und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Division of Materials Research.
Abstract (Originalsprache)
We describe the synthesis and characterization of supramolecular networks based on charge‐assisted hydrogen bonding interactions of guanidinium and oxyanion functionalities. Although they are constructed entirely of small‐molecule components, these materials display properties such as a glass transition and time‐ and temperature‐dependent viscoelastic rheological behavior. These properties can be tuned by the choice of each network component: T g varies by over 50°C in the studied networks, and relaxation times scaled with changes to T g . However, these supramolecular materials are inherently degradable and thermally reversible as no covalent macromolecular structure is formed.
Förderung
- Division of Materials Research
Zitieren
APA
Venablerose, O. G., Pelt, E. B. V., DeKoekkoek, A. L., & Larsen, M. B. (2025). Viscoelastic Supramolecular Networks Based on Guanidinium‐Oxyanion Interactions. Journal of Polymer Science, 63(11), 2363-2370. https://doi.org/10.1002/pol.20250048
Vancouver
Venablerose OG, Pelt EBV, DeKoekkoek AL, Larsen MB. Viscoelastic Supramolecular Networks Based on Guanidinium‐Oxyanion Interactions. Journal of Polymer Science. 2025;63(11):2363-2370. doi:10.1002/pol.20250048
BibTeX
@article{Venablerose2025,
author = {Venablerose, Oliver G. and Pelt, Evan B. Van and DeKoekkoek, Ava L. and Larsen, Michael B.},
title = {Viscoelastic Supramolecular Networks Based on Guanidinium‐Oxyanion Interactions},
journal = {Journal of Polymer Science},
year = {2025},
volume = {63},
number = {11},
pages = {2363--2370},
doi = {10.1002/pol.20250048}
}
EUVIMED